Introduction -[Current Good Manufacturing Practices (CGMP)]

5.0(1)
Studied by 10 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/47

flashcard set

Earn XP

Description and Tags

Proverbs 16:3

Last updated 5:48 PM on 5/19/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

48 Terms

1
New cards

Current Good Manufacturing Practices (CGMP)

This was first promulgated by the US FDA in 1963.

2
New cards

US FDA

Current Good Manufacturing Practices (CGMP) was first promulgated by the______ in 1963.

3
New cards

1963

Current Good Manufacturing Practices (CGMP) was first promulgated by the US FDA in _____ .

4
New cards

Current Good Manufacturing Practices (CGMP)

These were established to ensure that MINIMUM STANDARDS are met for drug product quality

5
New cards

Quality

It refers to the perception of the degree to which the product or service meets the customer's expectations.

6
New cards

Good Manufacturing Practice (GMP)

Part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use. (WHO 2007)

7
New cards

WHO 2007

According to ____.

Good Manufacturing Practice (GMP) is a part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use.

8
New cards
  1. Food

  2. Cosmetics

  3. Medical Devices

  4. Household and Urban Substances

FDA Regulated Products include [4]

9
New cards

Good Manufacturing Practice (GMP)

System of quality assurance aimed at ensuring that products are consistently manufactured to a quality appropriate for intended use. (AO 43 s. 1999)

10
New cards

AO 43 s. 1999

According to _____.

Good Manufacturing Practice (GMP) is a system of quality assurance aimed at ensuring that products are consistently manufactured to a quality appropriate for intended use.

11
New cards

Good Manufacturing Practice (GMP)

This is system of quality assurance aimed at ensuring that products are consistently manufactured to a quality appropriate for intended use and is concerned with manufacturing and quality control process and procedures.(AO 43 s. 1999)

12
New cards

AO 43 s. 1999

According to _____.

Good Manufacturing Practice (GMP) is a system of quality assurance aimed at ensuring that products are consistently manufactured to a quality appropriate for intended use and is concerned with manufacturing and quality control process and procedures.

13
New cards

Good Manufacturing Practice (GMP)

Part of quality assurance which ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use. (WHO 2007)

14
New cards

WHO 2007

According to _____.

Good Manufacturing Practice (GMP) is a part of quality assurance which ensures that medicinal products are consistently produced and controlled to the quality standards appropriate to their intended use.

15
New cards

Quality Assurance (QA)

The sum total of the organized arrangements made with the object of ensuring that medicinal products are of the quality required for their intended use.

16
New cards

Quality Assurance (QA)

It is a wide-ranging concept which covers all matters which individually or collectively influence the quality of a product.

17
New cards
  • Man

  • Materials

  • Method

  • Machine

4Ms (Factors Influencing Quality)

18
New cards

AO 43 s. 1999

[PHILIPPINES GMP REGULATION]

Adoption of the 1st edition of the CGMP Guidelines by the BFAD (former FDA).

a. FDA Memorandum Circular 2012-004

b. AO 2012-0008

c. AO 43 s. 1999

19
New cards

AO 2012-0008

[PHILIPPINES GMP REGULATION]

Adoption and implementation of the PIC/S GMP as the standard for the manufacture of pharmaceutical products.

a. FDA Memorandum Circular 2012-004

b. AO 2012-0008

c. AO 43 s. 1999

20
New cards

FDA Memorandum Circular 2012-004

[PHILIPPINES GMP REGULATION]

The Philippine FDA mandated all drug manufacturers to ensure strict and full compliance to the newly adopted PIC/S GMP.

a. FDA Memorandum Circular 2012-004

b. AO 2012-0008

c. AO 43 s. 1999

21
New cards

Pharmaceutical Inspection Convention (PIC)

[PHILIPPINES GMP REGULATION]

European member countries.

a. Pharmaceutical Inspection Convention (PIC)

b. Pharmaceutical Inspection Co-operation Scheme (PICS)

22
New cards

Pharmaceutical Inspection Co-operation Scheme (PICS)

[PHILIPPINES GMP REGULATION]

Non-European member countries.

a. Pharmaceutical Inspection Convention (PIC)

b. Pharmaceutical Inspection Co-operation Scheme (PICS)

23
New cards

Chapter I

[Identify the Chapters of PIC/s GMP]

Quality Management

a. Chapter I

b. Chapter II

c. Chapter III

d. Chapter IV

e. Chapter V

f. Chapter VI

g. Chapter VII

h. Chapter VIII

i. Chapter IX

24
New cards

Chapter II

[Identify the Chapters of PIC/s GMP]

Personnel

a. Chapter I

b. Chapter II

c. Chapter III

d. Chapter IV

e. Chapter V

f. Chapter VI

g. Chapter VII

h. Chapter VIII

i. Chapter IX

25
New cards

Chapter III

[Identify the Chapters of PIC/s GMP]

Premises and equipment

a. Chapter I

b. Chapter II

c. Chapter III

d. Chapter IV

e. Chapter V

f. Chapter VI

g. Chapter VII

h. Chapter VIII

i. Chapter IX

26
New cards

Chapter IV

[Identify the Chapters of PIC/s GMP]

Documentation

a. Chapter I

b. Chapter II

c. Chapter III

d. Chapter IV

e. Chapter V

f. Chapter VI

g. Chapter VII

h. Chapter VIII

i. Chapter IX

27
New cards

Chapter V

[Identify the Chapters of PIC/s GMP]

Production

a. Chapter I

b. Chapter II

c. Chapter III

d. Chapter IV

e. Chapter V

f. Chapter VI

g. Chapter VII

h. Chapter VIII

i. Chapter IX

28
New cards

Chapter VI

[Identify the Chapters of PIC/s GMP]

Quality control (QC)

a. Chapter I

b. Chapter II

c. Chapter III

d. Chapter IV

e. Chapter V

f. Chapter VI

g. Chapter VII

h. Chapter VIII

i. Chapter IX

29
New cards

Chapter VII

[Identify the Chapters of PIC/s GMP]

Contract manufacture and analysis

a. Chapter I

b. Chapter II

c. Chapter III

d. Chapter IV

e. Chapter V

f. Chapter VI

g. Chapter VII

h. Chapter VIII

i. Chapter IX

30
New cards

Chapter VIII

[Identify the Chapters of PIC/s GMP]

Complaints and product recall

a. Chapter I

b. Chapter II

c. Chapter III

d. Chapter IV

e. Chapter V

f. Chapter VI

g. Chapter VII

h. Chapter VIII

i. Chapter IX

31
New cards

Chapter IX

[Identify the Chapters of PIC/s GMP]

Self inspection

a. Chapter I

b. Chapter II

c. Chapter III

d. Chapter IV

e. Chapter V

f. Chapter VI

g. Chapter VII

h. Chapter VIII

i. Chapter IX

32
New cards
  1. Repeatable

  2. Compliance

  3. Validated

  4. 4M + P (Man, Method, Materials, Machine + Premises and spaces)

  5. Documentation, DIR (Data Integrity Record)

  6. History

  7. Complaints and product recall

Requirements Summary of PIC/s GMP [7]

33
New cards
  1. All manufacturing processes are clearly defined, systematically reviewed, and shown to be capable of consistently manufacturing medicinal products of the required quality and complying with their specification.

  2. Critical steps of the manufacturing process and significant changes to the process are validated.

  3. All necessary facilities for GMP are provided, including:

    • appropriately qualified and trained personnel

    • adequate premises and space

    • suitable equipment and services

    • correct materials, containers and labels

    • approved procedures and instructions

    • suitable storage and transport

  4. Instructions and procedures are written in an instructional form in an unambiguous language specifically applicable to the facilities provided.

  5. Operators are trained to carry out procedures correctly; procedures should not be memorized but read from documents like the Master Formula.

  6. Records are made during manufacture which demonstrate that all required steps were taken and that the quantity and quality of the product was as expected. Any significant deviations are fully recorded and investigated.

  7. Records of manufacture and distribution, which enable the complete history of a batch to be traced, are retained in a comprehensible and accessible form.

  8. The distribution of the products minimizes any risk to their quality.

  9. A system is available to recall any batch of product from sale or supply.

  10. Complaints about marketed products are examined. The cause of quality defects is investigated, and appropriate measures are taken to address defects and prevent reoccurrence.

Basic Requirements of GMP (PIC/s 2009):

34
New cards

TRUE

Basic Requirements of GMP (PIC/s 2009):

TRUE OR FALSE:

All manufacturing processes are clearly defined, systematically reviewed, and shown to be capable of consistently manufacturing medicinal products of the required quality and complying with their specification.

35
New cards

TRUE

Basic Requirements of GMP (PIC/s 2009):

TRUE OR FALSE:

Critical steps of the manufacturing process and significant changes to the process are validated.

36
New cards

TRUE

Basic Requirements of GMP (PIC/s 2009)

TRUE OR FALSE:

All necessary facilities for GMP are provided, including:

  • appropriately qualified and trained personnel

  • adequate premises and space

  • suitable equipment and services

  • correct materials, containers and labels

  • approved procedures and instructions

  • suitable storage and transport

37
New cards

Instructional form

Basic Requirements of GMP (PIC/s 2009):

Instructions and procedures are written in an ____ form in an unambiguous language specifically applicable to the facilities provided.

38
New cards

Operators

Basic Requirements of GMP (PIC/s 2009):

They are trained to carry out procedures correctly

39
New cards

Memorized

Basic Requirements of GMP (PIC/s 2009):

Operators are trained to carry out procedures correctly; procedures should not be _____but read from documents like the Master Formula.

40
New cards

Records

Basic Requirements of GMP (PIC/s 2009):

These are made during manufacture which demonstrate that all required steps were taken and that the quantity and quality of the product was as expected. Any significant deviations are fully recorded and investigated.

41
New cards

Deviations

Basic Requirements of GMP (PIC/s 2009):

Records are made during manufacture which demonstrate that all required steps were taken and that the quantity and quality of the product was as expected. Any significant_______ are fully recorded and investigated.

42
New cards

TRUE

Basic Requirements of GMP (PIC/s 2009):

TRUE OR FALSE:

Records of manufacture and distribution, which enable the complete history of a batch to be traced, are retained in a comprehensible and accessible form.

43
New cards

TRUE

Basic Requirements of GMP (PIC/s 2009):

TRUE OR FALSE:

The DISTRIBUTION of the products minimizes any risk to their quality.

44
New cards

TRUE

Basic Requirements of GMP (PIC/s 2009):

TRUE OR FALSE:

A system is available to recall any batch of product from sale or supply.

45
New cards

TRUE

Basic Requirements of GMP (PIC/s 2009):

TRUE OR FALSE:

COMPLAINTS about marketed products are examined. The cause of QUALITY DEFECTS is investigated, and appropriate measures are taken to address defects and prevent reoccurrence.

46
New cards

Complaints

Basic Requirements of GMP (PIC/s 2009):

_____ about marketed products are examined. The cause of QUALITY DEFECTS is investigated, and appropriate measures are taken to address defects and prevent reoccurrence.

47
New cards

Quality Defects

Basic Requirements of GMP (PIC/s 2009)

Complaints about marketed products are examined. The cause of _____ is investigated, and appropriate measures are taken to address defects and prevent reoccurrence.

48
New cards
  1. Ensures Product Quality and Safety

    • Guarantees that medicines are safe, effective, and of good quality.

    • Prevents substandard, con

  2. Promotes Consistency in Manufacturing

    • Ensures uniformity in every batch produced.

    • Reduces batch-to-batch variation through standardized procedure

  3. Prevents Contamination and Mix-Ups

    • Requires proper facility design, sanitation, personnel hygiene, and equipment maintenance.

    • Minimizes cross-contamination and labeling errors.

  4. Ensures Proper Documentation and Traceability

    • Requires complete and accurate records (SOPs, batch records).

    • Allows tracing of errors, deviations, or product recalls when needed.

  5. Strengthens Quality Assurance and Quality Control Systems

    • Establishes clear roles for QA and QC in testing, approval, and release of products.

    • Ensures compliance with pharmacopeial and regulatory standards.

  6. Protects Public Health

    • Ensures patients receive medicines that meet safety and efficacy requirements.

    • Reduces risks of therapeutic failure or adverse drug reactions.

  7. Supports Regulatory ComplianceProtects Public Health

    • Compliance with cGMP is mandatory for licensing and product registration.

    • Prevents regulatory sanctions, recalls, and plant shutdowns

  8. Enhances Professional Accountability

    • Ensures pharmacists and manufacturers uphold ethical and professional responsibilities

    • Promotes accountability at every stage of production.

Importance of the Provisions of cGMP: